100,000 Shares in Enzo Biochem, Inc. (NYSE:ENZ) Bought by BBR Partners LLC

Posted by Donald Scott on Nov 29th, 2024

BBR Partners LLC bought a new stake in shares of Enzo Biochem, Inc. (NYSE:ENZ – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 100,000 shares of the medical research company’s stock, valued at approximately $112,000. BBR Partners LLC owned approximately 0.19% of Enzo Biochem at the end of the most recent reporting period.

Separately, Renaissance Technologies LLC lifted its holdings in Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after purchasing an additional 64,417 shares during the last quarter. 36.90% of the stock is currently owned by hedge funds and other institutional investors.

Enzo Biochem Stock Down 1.0 %

Shares of NYSE ENZ opened at $1.03 on Friday. Enzo Biochem, Inc. has a 12 month low of $0.93 and a 12 month high of $1.50. The business’s 50 day moving average is $1.11 and its two-hundred day moving average is $1.11.

Enzo Biochem Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 38.83%. The ex-dividend date of this dividend is Friday, November 15th.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a report on Saturday, November 23rd. They set a “hold” rating for the company.

Get Our Latest Stock Report on Enzo Biochem

About Enzo Biochem

(Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.